Race Oncology Limited (ASX: RAC)
Australia
· Delayed Price · Currency is AUD
1.415
+0.090 (6.79%)
Dec 20, 2024, 4:10 PM AEST
Race Oncology Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Net Income | -13.82 | -13.82 | -9.92 | -11.2 | -6.34 | -3.85 | |
| Depreciation & Amortization | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | |
| Stock-Based Compensation | 1.43 | 1.43 | 0.59 | 3.07 | 2.28 | 1.09 | |
| Other Operating Activities | - | - | 0.08 | 0.04 | -0.01 | 0 | |
| Change in Accounts Receivable | 1.6 | 1.6 | -1.64 | 0.07 | -0.08 | -0.05 | |
| Change in Accounts Payable | 0.68 | 0.68 | -0.27 | 0.89 | 0.28 | 0.05 | |
| Change in Other Net Operating Assets | 0.28 | 0.28 | 0.23 | 0.59 | -1.11 | 0 | |
| Operating Cash Flow | -9.55 | -9.55 | -10.65 | -6.26 | -4.7 | -2.46 | |
| Issuance of Common Stock | 5.21 | 5.21 | - | 30.98 | 12.79 | 3.35 | |
| Other Financing Activities | -0 | -0 | -1.28 | -0.46 | -0.51 | -0.14 | |
| Financing Cash Flow | 5.21 | 5.21 | -1.28 | 30.51 | 12.28 | 3.21 | |
| Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -0.09 | -0.04 | 0.01 | -0 | |
| Net Cash Flow | -4.33 | -4.33 | -12.02 | 24.22 | 7.59 | 0.74 | |
| Free Cash Flow | -9.55 | -9.55 | -10.65 | -6.26 | -4.7 | -2.46 | |
| Free Cash Flow Margin | -238.43% | -238.43% | -339.83% | -884.12% | -1212.64% | -1545.50% | |
| Free Cash Flow Per Share | -0.06 | -0.06 | -0.07 | -0.04 | -0.04 | -0.02 | |
| Cash Income Tax Paid | - | - | - | - | -0.39 | -0.16 | |
| Levered Free Cash Flow | -4.83 | -4.83 | -7.36 | -2.1 | -2.14 | -1.26 | |
| Unlevered Free Cash Flow | -4.83 | -4.83 | -7.36 | -2.1 | -2.14 | -1.26 | |
| Change in Net Working Capital | -2.51 | -2.51 | 1.68 | -1.55 | 0.72 | 0.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.